ESR1 and cancer: Ang 2 exhibits such revival of dormant ER + breast cancer cells in the vascular niche of bone marrow either by directly inhibiting Ang 1-Tie2 signaling, or via stimulating surface integrin β1 receptors in these dormant cancer cells [185].